Cerecor to acquire genomic medicine firm in stock deal

A Rockville biopharmaceutical firm has plans to buy a genomic medicine company in a deal worth up to $22.6 million and is looking at its options for some of its existing assets.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *